A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex) Versus Placebo in Patients With Early Prostate Cancer
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms EPC
- Sponsors AstraZeneca
- 07 Jan 2009 Status changed from active, no longer recruiting to completed, as reported by Clinicaltrials.gov.
- 11 Apr 2008 The expected completion date for this trial is now 1 Sep 2008 as reported by ClinicalTrials.gov.
- 20 Feb 2007 New trial record.